(Total Views: 700)
Posted On: 02/16/2017 8:53:12 PM
Post# of 30066
Here's the other two for Levodopa-Induced Dyskinesia
Addex is in Phase II
http://www.addextherapeutics.com/rd/pipeline/
Adamas - ADS-5102
http://www.adamaspharma.com/pipeline/
http://www.addextherapeutics.com/rd/pipeline/We submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for ADS-5102 in October 2016. The FDA has designated that LID in patients with PD is an orphan disease. There are currently no approved drugs in the United States or Europe for the treatment of LID in patients with PD.
Eltoprazine also has possibilities in other indications besides PD-LID
http://www.amarantus.com/therapeutics-pipelin...ltoprazine
Addex is in Phase II
http://www.addextherapeutics.com/rd/pipeline/
Adamas - ADS-5102
http://www.adamaspharma.com/pipeline/
http://www.addextherapeutics.com/rd/pipeline/We submitted a New Drug Application (NDA) with the U.S. Food and Drug Administration (FDA) for ADS-5102 in October 2016. The FDA has designated that LID in patients with PD is an orphan disease. There are currently no approved drugs in the United States or Europe for the treatment of LID in patients with PD.
Eltoprazine also has possibilities in other indications besides PD-LID
http://www.amarantus.com/therapeutics-pipelin...ltoprazine
(4)
(0)
